Jaegil Kim
Overview
Explore the profile of Jaegil Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
17825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DAngelo S, Druta M, Van Tine B, Liebner D, Schuetze S, Tap W, et al.
J Clin Oncol
. 2025 Jan;
JCO2401466.
PMID: 39836945
Purpose: The cancer/testis antigen New York esophageal squamous cell carcinoma 1 (NY-ESO-1) is a promising target in myxoid/round cell liposarcoma (MRCLS). Methods: In this pilot study, we assessed the adoptive...
2.
Yoon K, Kim Y, Jung S, Ryu J, Kim K, Lee E, et al.
Exp Mol Med
. 2024 Nov;
56(11):2382-2394.
PMID: 39482530
Early-onset breast cancer is known for its aggressive clinical characteristics and high prevalence in East Asian countries, but a comprehensive understanding of its molecular features is still lacking. In this...
3.
Ravi A, Hellmann M, Arniella M, Holton M, Freeman S, Naranbhai V, et al.
Nat Genet
. 2023 Apr;
55(5):807-819.
PMID: 37024582
Anti-PD-1/PD-L1 agents have transformed the treatment landscape of advanced non-small cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying response to checkpoint inhibitors in NSCLC, we...
4.
Alexandrov L, Kim J, Haradhvala N, Huang M, Ng A, Wu Y, et al.
Nature
. 2023 Jan;
614(7948):E41.
PMID: 36697836
No abstract available.
5.
Rheinbay E, Nielsen M, Abascal F, Wala J, Shapira O, Tiao G, et al.
Nature
. 2023 Jan;
614(7948):E40.
PMID: 36697832
No abstract available.
6.
Kim H, Westerman K, Smith K, Chiou J, Cole J, Majarian T, et al.
Diabetologia
. 2022 Dec;
66(3):495-507.
PMID: 36538063
Aims/hypothesis: Type 2 diabetes is highly polygenic and influenced by multiple biological pathways. Rapid expansion in the number of type 2 diabetes loci can be leveraged to identify such pathways....
7.
Gyurdieva A, Zajic S, Chang Y, Houseman E, Zhong S, Kim J, et al.
Nat Commun
. 2022 Sep;
13(1):5296.
PMID: 36075914
Autologous T cells transduced to express a high affinity T-cell receptor specific to NY-ESO-1 (letetresgene autoleucel, lete-cel) show promise in the treatment of metastatic synovial sarcoma, with 50% overall response...
8.
Roh W, Geffen Y, Cha H, Miller M, Anand S, Kim J, et al.
Cancer Res
. 2022 Aug;
82(21):3917-3931.
PMID: 36040373
Significance: Integrative analysis of multiomic and drug dependency data uncovers robust lung adenocarcinoma expression subtypes with unique therapeutic vulnerabilities and subtype-specific biomarkers of response.
9.
Freeman S, Sade-Feldman M, Kim J, Stewart C, Gonye A, Ravi A, et al.
Cell Rep Med
. 2022 Mar;
3(2):100500.
PMID: 35243413
Immune checkpoint blockade (CPB) improves melanoma outcomes, but many patients still do not respond. Tumor mutational burden (TMB) and tumor-infiltrating T cells are associated with response, and integrative models improve...
10.
Merino J, Dashti H, Sarnowski C, Lane J, Todorov P, Udler M, et al.
Nat Hum Behav
. 2021 Aug;
6(1):155-163.
PMID: 34426670
Dietary intake is a major contributor to the global obesity epidemic and represents a complex behavioural phenotype that is partially affected by innate biological differences. Here, we present a multivariate...